Merck & Co Inc: (NYSE: MRK)
$45.99
-0.38 (-0.82%)
Volume 21,686,502
May 17 04:00 PM ET
Zacks Rank: 3-Hold 
| #3 |
Comparison to Industry
Industry / Sector Report
Industry: LARGE CAP PHARMA
Zacks Industry Rank: 
Rank in Industry:
Recommendations and Estimates
| Company | Industry | SP500 | |
|---|---|---|---|
| Average Recommendation (1=Buy, 5=Sell) | 1.75 | 2.02 | 9.99 |
| Current Quarter Estimate | 0.83 | 24.11 | 25.88 |
| Year Ago Quarter Estimate | 1.05 | 20.48 | 24.24 |
| Next Quarter Estimate | 0.92 | 24.66 | 26.63 |
| Next Year Estimate | 3.78 | 21.68 | 25.43 |
Growth Rates
| Company | Industry | SP500 | |
|---|---|---|---|
| This Year (-8.6) | -8.60 | -3.40 | 11.40 |
| Next Year (8.3) | 8.30 | 7.00 | 6.50 |
| Last 5 Years | 4.60 | 7.10 | 5.70 |
| Next 5 Years | 3.20 | 6.40 | NA |
Financials
| Company | Industry | ||
|---|---|---|---|
| Price/Earnings (TTM) | 12.50 | 15.84 | |
| Price/Book (MRQ) | 2.52 | 3.83 | |
| Price/Cash Flow (MRFY) | 7.47 | 12.06 | |
| Dividend Yield | 3.74% | 2.85% | |
| Net Profit Margin (TTM) | 14.10% | 15.61% | |
| Return on Equity (TTM) | 19.88% | 23.70% | |
| Debt to Equity (MRQ) | 0.29 | 25.54 |
MRQ = Most Recent Quarter TTM = Trailing Twelve Months MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.
